MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s disease: Study Design

    T. Simuni, B. Fiske, K. Merchant, C. Coffey, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, C. Venuto, L. Trusso, L. Baker, M. Kostrzebski, T. Ward, G. Rafaloff (Chicago, IL, USA)

    Objective: To assess the safety and tolerability of nilotinib (150-300 mg QD) in moderate/advanced and early/de novo Parkinson disease (PD) participants. Background: Studies in cell…
  • 2018 International Congress

    The Interface of advanced therapies as Parkinson’s disease progresses – case reports

    C. Liang, S. Williams, L. Jones, C. Sue, P. Silberstein (St Leonards, Australia)

    Objective: To explore the practical benefits and challenges of adding duodenal levodopa-carbidopa intestinal gel infusion (LCIG) to subthalamic nucleus deep brain stimulation (STN DBS) in…
  • 2018 International Congress

    Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients

    B. Gonenli Kocer, E. Ozturk, S. Comoglu (Ankara, Turkey)

    Objective: To evaluate the demographic, motor and non-motor clinical characteristics of Turkish Parkinson’s disease (PD) patients in our Movement Disorders Outpatient Clinic. Background: Although PD…
  • 2018 International Congress

    Absence of wearing-off in Parkinson’s disease patients with treatment beyond 10 years

    Q. Wei, R. Ou, Y. Wu, X. Yuan, Y. Hou, H. Liu, L. Zhang, Y. Chen, B. Cao, X. Chen, H. Shang (Chengdu, China)

    Objective: This study aims to explore the determinants for absence of wearing-off in patients with Parkinson’s disease (PD) based on a large cohort of Chinese…
  • 2018 International Congress

    Effects of Korean Medicine on Postural Instability and Gait Difficulty in Patient with Parkinsonism

    HM. Lee, SB. Yang, SY. Cho, JM. Park, CN. Ko, SU. Park (Seoul, Republic of Korea)

    Objective: The purpose of this study was to investigate the effects of Korean Medicine on postural instability and gait difficulty (PIGD) in patient with parkinsonism.…
  • 2018 International Congress

    Can blood biomarkers differentiate Idiopathic Parkinson’s disease from Parkinson plus syndromes? A study from North Indian population

    R. Shree, M. Mulagala, M. Modi, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)

    Objective: To study the role of serum DJ-1 and Apo A1 in the differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes (PPS) in…
  • 2018 International Congress

    Juvenile parkinsonism associated with a novel HSD17B10 mutation in a patient with HSD10 disease

    M. Rosário, O. Moldovan, S. Reimão, I. Chendo, J. Crawford, M. Rosa, L. Guedes (Lisbon, Portugal)

    Objective: We describe the case of a female patient with HSD10 disease associated with parkinsonism, with a novel mutation in the HSD17B10 gene. Background: HSD10…
  • 2018 International Congress

    Hardware-related infections seen after implantable pulse generator replacement in Parkinson‘s patients who underwent Deep Brain Stimulation: A Single Center Experience

    A. Acarer, H. Biçeroğlu, E. Özgiray, Z. Çolakoğlu (Izmir, Turkey)

    Objective: To investigate the hardware-related infection frequency associated with implantable pulse generator ( IPG ) replacement in Parkinson's patients who underwent Deep Brain Stimulation (…
  • 2018 International Congress

    Mild Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation

    A. Troster, A. Abbott, F. Ponce, H. Shill, S. Oravivattanakul, G. Moguel-Cobos, N. Salins, A. Lieberman, K. Hanson (Phoenix, AZ, USA)

    Objective: To determine rates of mild cognitive impairment in Parkinson’s disease (PD-MCI) before and after deep brain stimulation (DBS) and to identify the specific cognitive…
  • 2018 International Congress

    Prevalence and characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data

    E. Viscidi, T. Dam, M. Juneja, L. Li, H. Krzywy, S. Eaton, S. Chen, S. Hall, A. Dilley (Cambridge, MA, USA)

    Objective: To estimate the prevalence of PSP in the United States (US) and present a profile of PSP patients. Background: Progressive supranuclear palsy (PSP) is…
  • « Previous Page
  • 1
  • …
  • 249
  • 250
  • 251
  • 252
  • 253
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley